Vericel

VCELNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$2.025 B

$39.55 -1.17%

Close of 21 Sept 2026

Revenue

$276.3M

#2166 by revenue

Earnings

$16.5M

#1933 by earnings

Shares outstanding

51,206,614

Latest filing cover page

P/E ratio

122.6

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#32Recursion PharmaceuticalsRXRX$2.13B
#33Kodiak SciencesKOD$2.04B
#34VericelVCEL$2.03B
#35MesoblastMESO$2.01B
#36Vir BiotechnologyVIR$1.84B

What if Vericel were worth as much as…

Open the what-if tool →

Gold $30.3T

$591,213.75

Per share 14,949× higher

Bitcoin $1.72T

$33,585.58

Per share 849× higher

Nvidia $5.48T

$107,014.65

Per share 2,706× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Vericel are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.